United Therapeutics (UTHR) Assets Average (2010 - 2026)

United Therapeutics (UTHR) has 17 years of Assets Average data on file, last reported at $7.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 3.4% year-over-year to $7.3 billion; the trailing twelve-month figure through Mar 2026 stood at $7.3 billion (down 3.4% YoY), and the FY2025 full-year result was $7.6 billion, up 4.91% from the prior year.
• Assets Average declined to $7.3 billion in Q1 2026, from $7.6 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $7.8 billion in Q2 2025 to a low of $3.4 billion in Q3 2024.
• A 5-year average of $6.3 billion and a median of $6.6 billion in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average tumbled 50.92% in 2024 and surged 126.87% in 2025, its largest moves.
• Tracing UTHR's Assets Average over 5 years: stood at $5.9 billion in 2022, then gained by 19.99% to $7.1 billion in 2023, then tumbled by 48.09% to $3.7 billion in 2024, then jumped by 106.76% to $7.6 billion in 2025, then dropped by 4.18% to $7.3 billion in 2026.
• Business Quant data shows UTHR's Assets Average at $7.3 billion in Q1 2026, $7.6 billion in Q4 2025, and $7.6 billion in Q3 2025.